share_log

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences | 6-K:Bright Minds Biosciences啓動突破性研究:Bmb-101治療失神性癲癇和發育性癲癇性腦病2期試驗
美股SEC公告 ·  2024/09/12 10:03
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息